Antagonistic actions at the neuromuscular junction. 1952

M J DALLEMAGNE, and E PHILIPPOT

UI MeSH Term Description Entries
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D009142 Musculoskeletal Physiological Phenomena Processes and properties of the MUSCULOSKELETAL SYSTEM. Musculoskeletal Physiologic Processes,Musculoskeletal Physiological Process,Musculoskeletal Physiological Processes,Musculoskeletal Physiology,Musculoskeletal Physiologic Process,Musculoskeletal Physiological Concepts,Musculoskeletal Physiological Phenomenon,Physiology, Musculoskeletal,Concept, Musculoskeletal Physiological,Concepts, Musculoskeletal Physiological,Musculoskeletal Physiological Concept,Phenomena, Musculoskeletal Physiological,Phenomenon, Musculoskeletal Physiological,Physiologic Process, Musculoskeletal,Physiologic Processes, Musculoskeletal,Process, Musculoskeletal Physiologic,Process, Musculoskeletal Physiological,Processes, Musculoskeletal Physiologic,Processes, Musculoskeletal Physiological
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D003472 Curare Plant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal muscle. These extracts are toxic and must be used with the administration of artificial respiration.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M J DALLEMAGNE, and E PHILIPPOT
September 1985, Agents and actions,
M J DALLEMAGNE, and E PHILIPPOT
January 1989, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
M J DALLEMAGNE, and E PHILIPPOT
January 1982, General pharmacology,
M J DALLEMAGNE, and E PHILIPPOT
April 1971, British journal of pharmacology,
M J DALLEMAGNE, and E PHILIPPOT
May 1972, The Journal of pharmacy and pharmacology,
M J DALLEMAGNE, and E PHILIPPOT
August 1979, The Journal of physiology,
M J DALLEMAGNE, and E PHILIPPOT
January 1948, The American journal of physiology,
M J DALLEMAGNE, and E PHILIPPOT
October 1966, British journal of pharmacology and chemotherapy,
M J DALLEMAGNE, and E PHILIPPOT
January 1985, Pharmacology,
M J DALLEMAGNE, and E PHILIPPOT
April 1993, Neuropharmacology,
Copied contents to your clipboard!